Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Diamyd Medical AB (publ)
DMNCurrent price
1.03 EUR
-0.012 EUR (-1.15%)
Last closed
12.84 SEK
Company
www.diamyd.com
ISIN
SE0005162880
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
1 395 147 914 SEK
Yield for 12 month
+70.87 %
1Y
3Y
5Y
10Y
15Y
DMN
Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes in adults (LADA); and Remygen, an immunomodulation therapy, that is in phase I/II clinical trial for the treatment of with type 1 diabetes, type 2 diabetes, and LADA. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in type 1 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was founded in 1984 and is headquartered in Stockholm, Sweden. Address: Kungsgatan 29, Stockholm, Sweden, 111 56
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+131 806 SEK
Last Year
+553 581 SEK
Current Quarter
+18 247 SEK
Last Quarter
+52 718 SEK
Current Year
-3 629 704 SEK
Last Year
-3 130 874 SEK
Current Quarter
-822 260 SEK
Last Quarter
-14 200 452 SEK
Key Figures DMN
1 year
3 years
5 years
10 years
EBITDA
-143 661 236 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-43.54 %
PEG Ratio
–
Return On Equity TTM
-96.32 %
Wall Street Target Price
–
Revenue TTM
131 805 SEK
Book Value
1.48 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-75.7 %
Dividend Yield
–
Gross Profit TTM
-3 130 873 SEK
Earnings per share
-1.58 SEK
Diluted Eps TTM
-1.58 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-59.4 %
Profit Margin
–
Dividend Analytics DMN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DMN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation DMN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6560.339
Price Sales TTM
10584.949
Enterprise Value EBITDA
-7.2438
Price Book MRQ
7.0406
Financials DMN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DMN
For 52 weeks
6.5 SEK
25.35 SEK
50 Day MA
14.21 SEK
Shares Short Prior Month
–
200 Day MA
13.57 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart